S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention
DC Element | Wert | Sprache |
---|---|---|
dc.contributor.author | Leiter, Ulrike | |
dc.contributor.author | Heppt, Markus V. | |
dc.contributor.author | Steeb, Theresa | |
dc.contributor.author | Alter, Mareike | |
dc.contributor.author | Amaral, Teresa | |
dc.contributor.author | Bauer, Andrea | |
dc.contributor.author | Bechara, Falk G. | |
dc.contributor.author | Becker, Jürgen C. | |
dc.contributor.author | Breitbart, Eckhard W. | |
dc.contributor.author | Breuninger, Helmut | |
dc.contributor.author | Diepgen, Thomas | |
dc.contributor.author | Dirschka, Thomas | |
dc.contributor.author | Eigentler, Thomas | |
dc.contributor.author | ElGammal, A. K. Stephan | |
dc.contributor.author | Felcht, Moritz | |
dc.contributor.author | Flaig, Michael J. | |
dc.contributor.author | Follmann, Markus | |
dc.contributor.author | Fritz, Klaus | |
dc.contributor.author | Grabbe, Stephan | |
dc.contributor.author | Greinert, Rüdiger | |
dc.contributor.author | Gutzmer, Ralf | |
dc.contributor.author | Hauschild, Axel | |
dc.contributor.author | Hillen, Uwe | |
dc.contributor.author | Ihrler, Stephan | |
dc.contributor.author | John, Swen Malte | |
dc.contributor.author | Kofler, Lukas | |
dc.contributor.author | Koelbl, Oliver | |
dc.contributor.author | Krause-Bergmann, Albrecht | |
dc.contributor.author | Kraywinkel, Klaus | |
dc.contributor.author | Krohn, Steffen | |
dc.contributor.author | Langer, Thomas | |
dc.contributor.author | Loquai, Carmen | |
dc.contributor.author | Löser, Christoph R. | |
dc.contributor.author | Mohr, Peter | |
dc.contributor.author | Nashan, Dorothée | |
dc.contributor.author | Nothacker, Monika | |
dc.contributor.author | Pfannenberg, Christina | |
dc.contributor.author | Salavastru, Carmen | |
dc.contributor.author | Schmitz, Lutz | |
dc.contributor.author | Stockfleth, Eggert | |
dc.contributor.author | Szeimies, Rolf-Markus | |
dc.contributor.author | Ulrich, Claas | |
dc.contributor.author | Voelter-Mahlknecht, Susanne | |
dc.contributor.author | Vordermark, Dirk | |
dc.contributor.author | Weichenthal, Michael | |
dc.contributor.author | Welzel, Julia | |
dc.contributor.author | Wermker, Kai | |
dc.contributor.author | Wiegand, Susanne | |
dc.contributor.author | Garbe, Claus | |
dc.contributor.author | Berking, Carola | |
dc.date.accessioned | 2024-01-04T10:28:37Z | - |
dc.date.available | 2024-01-04T10:28:37Z | - |
dc.date.issued | 2023 | |
dc.identifier.issn | 1610-0379 | |
dc.identifier.uri | http://osnascholar.ub.uni-osnabrueck.de/handle/unios/72876 | - |
dc.description | Cited by: 0; All Open Access, Hybrid Gold Open Access | |
dc.description.abstract | Actinic keratosis (AK) are common lesions in light-skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a major disease burden, especially among the elderly. To establish an evidence-based framework for clinical decision making, the guideline “actinic keratosis and cutaneous squamous cell carcinoma” was updated and expanded by the topics cutaneous squamous cell carcinoma in situ (Bowen's disease) and actinic cheilitis. The guideline is aimed at dermatologists, general practitioners, ear nose and throat specialists, surgeons, oncologists, radiologists and radiation oncologists in hospitals and office-based settings, as well as other medical specialties, policy makers and insurance funds involved in the diagnosis and treatment of patients with AK and cSCC. A separate guideline exists for patients and their relatives. In this part, we will address aspects relating to epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention. © 2023 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by Wiley-VCH GmbH on behalf of Deutsche Dermatologische Gesellschaft. | |
dc.language.iso | en | |
dc.publisher | John Wiley and Sons Inc | |
dc.relation.ispartof | JDDG - Journal of the German Society of Dermatology | |
dc.subject | Aged | |
dc.subject | Bowen's Disease | |
dc.subject | Carcinoma, Squamous Cell | |
dc.subject | Humans | |
dc.subject | Keratosis, Actinic | |
dc.subject | Skin | |
dc.subject | Skin Neoplasms | |
dc.subject | actinic cheilitis | |
dc.subject | actinic keratosis | |
dc.subject | adjuvant radiotherapy | |
dc.subject | advanced cancer | |
dc.subject | Article | |
dc.subject | Bowen disease | |
dc.subject | cancer classification | |
dc.subject | cancer diagnosis | |
dc.subject | cancer epidemiology | |
dc.subject | cancer palliative therapy | |
dc.subject | cancer prevention | |
dc.subject | cancer prognosis | |
dc.subject | cancer recurrence | |
dc.subject | cancer staging | |
dc.subject | cancer surgery | |
dc.subject | consensus | |
dc.subject | disease surveillance | |
dc.subject | evidence based practice | |
dc.subject | field cancerization | |
dc.subject | follow up | |
dc.subject | head and neck surgery | |
dc.subject | high risk population | |
dc.subject | histopathology | |
dc.subject | human | |
dc.subject | immune deficiency | |
dc.subject | lymph node dissection | |
dc.subject | metastasis | |
dc.subject | nomenclature | |
dc.subject | non invasive measurement | |
dc.subject | non invasive procedure | |
dc.subject | occupational disease | |
dc.subject | oncogenesis and malignant transformation | |
dc.subject | phase 1 clinical trial (topic) | |
dc.subject | phase 2 clinical trial (topic) | |
dc.subject | postoperative care | |
dc.subject | postoperative radiotherapy | |
dc.subject | practice guideline | |
dc.subject | primary prevention | |
dc.subject | primary tumor | |
dc.subject | prophylactic lymphadenectomy | |
dc.subject | prophylactic surgical procedure | |
dc.subject | risk factor | |
dc.subject | squamous cell skin carcinoma | |
dc.subject | systemic therapy | |
dc.subject | vulnerable population | |
dc.subject | actinic keratosis | |
dc.subject | aged | |
dc.subject | Bowen disease | |
dc.subject | pathology | |
dc.subject | skin | |
dc.subject | skin tumor | |
dc.subject | squamous cell carcinoma | |
dc.title | S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention | |
dc.type | journal article | |
dc.identifier.doi | 10.1111/ddg.15256 | |
dc.identifier.scopus | 2-s2.0-85174195158 | |
dc.identifier.url | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85174195158&doi=10.1111%2fddg.15256&partnerID=40&md5=b8130c9bb795f87ca949e3596b3a04d6 | |
dc.description.volume | 21 | |
dc.description.issue | 11 | |
dc.description.startpage | 1422 – 1433 | |
dcterms.isPartOf.abbreviation | JDDG J. German Soc. Dermatol. | |
local.import.remains | affiliations : Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuernberg, (CCC ER-EMN), Erlangen, Germany; Center of Dermatooncology, University Department of Dermatooncology, Eberhard-Karls-University Tuebingen, Tübingen, Germany; Department of Dermatology, Johannes Wesling Medical Center, Ruhr University Bochum Campus Minden, Minden, Germany; Department of Dermatology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany; Department of Dermatology, Venerology, and Allergology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany; Translational Skin Cancer Research (TSCR), DKTK Essen/Düsseldorf, University Medicine Essen, Essen, Germany; Association of Dermatological Prevention, Buxtehude, Germany; Institute of Clinical Social Medicine, University Heidelberg, Heidelberg, Germany; CentroDerm Wuppertal, Wuppertal, Germany; Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany; Clinic of Dermatology, Hospital Bethesda, Freudenberg, Germany; Department of Dermatosurgery, St. Josefhospital Heidelberg GmbH, Heidelberg, Germany; Department of Dermatology, Venereology und Allergy, University Medicine Mannheim, Mannheim, Germany; Department of Dermatology and Allergy, University Hospital, LMU Munich, München, Germany; German Guideline Program in Oncology, German Cancer Society, Berlin, Germany; Dermatology and Laser Consultation Center, Landau, Germany; Department of Dermatology, Mainz University Medical School, Mainz, Germany; Elbe Clinics Stade Buxtehude GmbH, Medical Center Buxtehude, Buxtehude, Germany; Department of Dermatology, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany; Department of Dermatology & Venerology, Vivantes Hospital Neukölln, Berlin, Germany; DERMPATH Muenchen, München, Germany; Department of Dermatology and Environmental Medicine, University of Osnabrueck, Institute for Interdisciplinary Dermatological Prevention and Rehabilitation (iDerm) at the University of Osnabrueck, Osnabrück, Germany; Study Center for Dermatosurgery, University Hospital Tuebingen, Eberhard-Karls-University, Tübingen, Germany; Clinic and Polyclinic for Radiooncology, University Medical Center Regensburg, Regensburg, Germany; Clinic for Trauma-, Orthopedics-, and Plastic Surgery, Department for Plastic-, Aesthetic- and Handsurgery, Gütersloh, Germany; Robert Koch-Institute, Berlin, Germany; German Social Accident Insurance (DGUV), Berlin, Germany; Department of Dermatology, Medical Center Bremen-Ost, Bremen, Germany; Skin Hospital, Skin Cancer Center, Ludwigshafen Hospital, Ludwigshafen, Germany; Department of Dermatology, Klinikum Dortmund, Dortmund, Germany; Association of the Scientific Medical Societies in Germany (AWMF), Institute for Medical Knowledge Management, c/o Philipps Universität Marburg, Marburg, Germany; Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University Tuebingen, Tübingen, Germany; Pediatric Dermatology Discipline, Dermato-oncology Research Facility, “Colentina” Clinical Hospital, Bucharest 020125, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of Dermatology and Allergology, Klinikum Vest GmbH, Recklinghausen, Germany; Dermatologie am Regierungsviertel, Berlin, Germany; Institute of Occupational Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany; Department of Radiation Oncology, Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany; Department of Dermatology, University Hospital Augsburg, Augsburg, Germany; Klinikum Osnabrueck, Department for Oral and Maxillofacial Surgery, Plastic and Aesthetic Operations, Osnabrück, Germany; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leipzig, Leipzig, Germany | |
local.import.remains | correspondence_address : U. Leiter; University Department of Dermatooncology, Eberhard-Karls-Universität, Tübingen, Liebermeisterstrasse 25, 72076, Germany; email: ulrike.leiter@med.uni-tuebingen.de | |
local.import.remains | pmid : 37840404 | |
local.import.remains | publication_stage : Final | |
crisitem.author.orcid | 0000-0001-5406-9458 | - |
crisitem.author.netid | JoSw269 | - |
Seitenaufrufe
1
Letzte Woche
0
0
Letzter Monat
0
0
geprüft am 17.05.2024